WVU Medicine Introduces Osseointegrated Prosthesis Technology

WVU Medicine is one of the first medical centers in the country to offer the Integrum Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA™) Implant System for the treatment of lower extremity amputations.

“Being one of the select facilities in the country to offer a multidisciplinary amputation clinic that incorporates this groundbreaking technology of osseointegration places our group at the forefront of amputee care,” Brock Lindsey, M.D., WVU Medicine orthopedic surgeon and Musculoskeletal Oncology and Adult Reconstruction director, said.

Osseointegration is a surgical procedure in which the prosthesis is integrated and permanently implanted into the bone. The revolutionary approach and viable alternative to a standard socket prosthesis offers a range of benefits for amputee patients, including improved mobility, enhanced comfort, reduced pressure, and stable attachment.

The OPRA™ Implant System is installed via two surgical procedures. In the first surgery, the fixture is implanted into the bone, which requires about six months of healing time for the bone to fully grow onto the fixture and anchor it. In the second surgery, an abutment is attached to the fixture and extends through the skin to connect to the external prosthesis. Another six months of rehabilitation is required, including fitting with a customized final prosthesis.

“We have already seen an increase in function and ease of use in our patients who have had the procedure,” Dr. Lindsey said.

The OPRA™ Implant System is the first and only FDA-approved technology for bone-anchored prostheses in the United States. In December 2020, the FDA approved OPRA for individuals who have transfemoral, or above-knee, amputations and those who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis.

For an appointment in the amputation clinic, call 304-598-4830. For more information on WVU Medicine Orthopedics, visit WVUMedicine.org/Ortho.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.